CONTROLLED SUBSTANCES ACT

Amendments

Drugs: treatment of gamma y-hydroxybutyrate and ketamine hydrochloride relative to the Controlled Substances Act (H.R. 2130), H55 [31JA]

Analyses

Pain Relief Promotion Act (H.R. 5544), S11116 [26OC]

Articles and editorials

Approve Pain Relief Promotion Bill—Senate Should Put a Quick End to Wyden's Filibuster and Pass Bill That Favors Pain-Killing Over Patient-Killing, S11214 [27OC]

Health, Not Suicide, S11214 [27OC]

Kill the Pain, Not the Patients, S11213 [27OC]

State's Rights, a State's Wrongs—Not Even Oregon Has a Right To Intrude on Federal Government's Traditional Regulatory Arena, S11214 [27OC]

Bills and resolutions

Death and dying: promote pain management and palliative care without permitting assisted suicide and euthanasia (see S. 2607), S4297 [23MY] (see H.R. 5544), H11193 [25OC]

Drugs: combat manufacture, traffic, import, and export of methamphetamine (see H.R. 4248), H2238 [12AP]

———protect children from drug traffickers (see H.R. 5312), H8405 [27SE]

———treatment of controlled substances (see H.R. 5326), H8406 [27SE]

Conference reports

Minimum Wage Increase, Taxpayer Relief, Medicare, Medicaid, and State Children's Health Insurance Program Corrections, Pain Management Promotion, and Small Business Programs Improvement (H.R. 2614), H10909-H11087 [25OC]

Descriptions

Drug Dealer Liability Act (H.R. 1042), H9536 [10OC]

Letters

Buprenorphine use in treating drug addiction: Donna E. Shalala, Sec. of HHS, S9112 [22SE]

Date-Rape Drug Prohibition Act: Ward Dean, H61 [31JA]

Drug Addiction Treatment Act: Representative Bliley, Committee on Commerce (House), H6376 [18JY]

———Representative Hyde, Committee on the Judiciary (House), H6376 [18JY]

Lists

Organizatons supporting legislation on pain management and palliative care promotion without permitting assisted suicide and euthanasia, S11213 [27OC]

Remarks in House

Courts: civil liability for illegal manufacturers and distributors of controlled substances (H.R. 1042), H9535-H9537 [10OC]

Death and dying: promote pain management and palliative care without permitting assisted suicide and euthanasia, H11211, H11212, H11252, H11261 [26OC]

Drugs: combat manufacture, traffic, import, and export of methamphetamine (H.R. 4248), H2125, H2126, H2127 [12AP], E545 [12AP]

———protect children from drug traffickers (H.R. 5312), H9950, H9951 [17OC], E1865 [19OC]

———registration requirements for practitioners who dispense narcotic drugs for maintenance or detoxification treatment (H.R. 2634), H6374-H6377 [18JY]

———treatment of gamma y-hydroxybutyrate and ketamine hydrochloride relative to the Controlled Substances Act (H.R. 2130), H55-H62 [31JA]

Remarks in Senate

Death and dying: promote pain management and palliative care without permitting assisted suicide and euthanasia, S11106, S11109, S11110 [26OC], S11207-S11216 [27OC], S11469 [1NO]

———promote pain management and palliative care without permitting assisted suicide and euthanasia (H.R. 2260), S14 [24JA]

———promote pain management and palliative care without permitting assisted suicide and euthanasia (H.R. 5544), S11116 [26OC]

———promote pain management and palliative care without permitting assisted suicide and euthanasia (S. 1272), S9842 [4OC], S10244 [11OC]

———promote pain management and palliative care without permitting assisted suicide and euthanasia (S. 2607), S4311 [23MY]

Drugs: registration requirements for practitioners who dispense narcotic drugs for maintenance or detoxification treatment, S9111-S9115 [22SE], S11892, S11893 [15DE]

Reports filed

Pain Relief Promotion Act: Committee on the Judiciary (Senate) (H.R. 2260) (S. Rept. 106-299), S4296 [23MY]

Statements

Buprenorphine Use in Treating Drug Addiction: Charles O'Brien, S9113 [22SE]

Pain Management and Palliative Care Promotion Without Permitting Assisted Suicide and Euthanasia: AMA, S11215 [27OC]

———C. Everett Koop, S11214 [27OC]

Pain Relief Promotion Act: American Cancer Society, S10244 [11OC]

Registration Requirements for Practitioners Who Dispense Narcotic Drugs for Maintenance or Detoxification Treatments: Representatives Bliley and McCollum, H8259 [27SE]

Texts of

H.R. 1042, Drug Dealer Liability Act, H9535 [10OC]

H.R. 2130, Date-Rape Drug Prohibition Act, H55-H57 [31JA]

H.R. 2634, Drug Addiction Treatment Act, H6374 [18JY], H7200 [27JY]

H.R. 5312, Protecting Our Children From Drugs Act, H9950 [17OC]

S. 2607, Pain Relief Promotion Act, S4312 [23MY]